Bryn Mawr Trust CO Quanterix Corp Transaction History
Bryn Mawr Trust CO
- $4.09 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Quanterix Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 800 shares of QTRX stock, worth $4,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800
Previous 800
-0.0%
Holding current value
$4,592
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding QTRX
# of Institutions
140Shares Held
36.1MCall Options Held
10.6KPut Options Held
13.8K-
Portolan Capital Management, LLC Boston, MA4.26MShares$24.5 Million1.45% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN4.24MShares$24.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$15.2 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA1.39MShares$8 Million0.38% of portfolio
About Quanterix Corp
- Ticker QTRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,987,600
- Market Cap $212M
- Description
- Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...